Fairfield Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-873
| Closed | -$155K | – | 67 |
|
|
2024
Q4 | $155K | Buy |
873
+3
| +0.3% | +$533 | 0.05% | 75 |
|
|
2024
Q3 | $172K | Buy |
870
+3
| +0.3% | +$592 | 0.06% | 78 |
|
|
2024
Q2 | $149K | Buy |
+867
| New | +$149K | 0.04% | 79 |
|
|
2023
Q4 | $171K | Buy |
1,102
+603
| +121% | +$93.4K | 0.07% | 79 |
|
|
2023
Q3 | $74.3K | Sell |
499
-146
| -23% | -$21.7K | 0.03% | 110 |
|
|
2023
Q2 | $86.9K | Buy |
645
+5
| +0.8% | +$673 | 0.03% | 107 |
|
|
2023
Q1 | $101K | Buy |
640
+4
| +0.6% | +$632 | 0.04% | 95 |
|
|
2022
Q4 | $103K | Sell |
636
-102
| -14% | -$16.5K | 0.05% | 90 |
|
|
2022
Q3 | $99.1K | Sell |
738
-100
| -12% | -$13.4K | 0.05% | 89 |
|
|
2022
Q2 | $128K | Buy |
838
+5
| +0.6% | +$766 | 0.06% | 78 |
|
|
2022
Q1 | $135K | Buy |
+833
| New | +$135K | 0.05% | 73 |
|